Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-24 @ 2:07 PM
NCT ID:
NCT00197795
Eligibility Criteria:
Inclusion Criteria:
* Informed written consent given for three immunizations with MenBVac and five blood tests
* Between the ages of 18 and 55 years inclusive at recruitment
Exclusion Criteria:
* Previous history of bacteriologically confirmed meningococcal disease
* History of clinically significant allergic sensitivity to any vaccine received in the past
* Immunodeficiency
* Any other acute or chronic systemic illness or dependence or abuse of drugs or alcohol
* Language difficulties sufficient to preclude adequate comprehension of the study information
* Possibility of pregnancy
* Receipt of any other vaccine in the previous 4 weeks
* Receipt of any group B vaccine in the past
* Current participation in any other clinical trial
* Generalized acute systemic illness and/or temp \>38C on day of vaccination deferral
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00197795
Study Brief:
Protocol Section:
NCT00197795